Stockreport

Why Corcept Therapeutics (CORT) Is Up 8.5% After First-in-Class Lifyorli FDA Cancer Approval – And What's Next [Yahoo! Finance]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior therapies including bevacizumab. The approval, based on the ROSELLA trial sho [Read more]